Drugs / Amitryptiline
Amitryptiline
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03199417 | May 2017 → May 2018 | osteoarthritis, knee | University of Michigan | Terminated | No outcome recorded Stop: Enrollment |
| Phase 31 trial | ||||||
| Phase 3 | NCT00704899 | Mar 2006 → Dec 2007 | fibromyalgia | Mahatma Gandhi Institute of Medical Sciences | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT01561209 Comparator | Mar 2012 → Jun 2014 | — | St Joseph University, Beirut, Lebanon | Completed | No outcome recorded |
| — | NCT01020162 Comparator | Sep 1995 → Dec 2006 | chronic pain syndrome | Göteborg University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amitryptiline | “Experimental - A multimodal topical cream treatment with Ketoprofen, Baclofen, Amitryptiline, and lidocaine in a carrier gel.” NCT03199417 ↗ |
| Known as | amitriptyline | “The objective of this prospective randomized and controlled study is to evaluate the efficacy and safety of low dose of amitriptyline (5 mg) in the management of chronic neck pain.” NCT01561209 ↗ |
| Known as | Amitryptiline - Saroten | “Amitryptiline - Saroten” NCT01020162 ↗ |